ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Injectable Drug Delivery Formulation Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-34R9117
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Injectable Drug Delivery Formulation Market Insights and Forecast to 2028
BUY CHAPTERS

Global Injectable Drug Delivery Formulation Market Research Report 2025

Code: QYRE-Auto-34R9117
Report
September 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Becton Dickinson and Company (US)
Baxter International, Inc. (US)
Gerresheimer AG (Germany)
Pfizer Inc. (US)
Schott AG (Germany)
Sandoz (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (US)

Injectable Drug Delivery Formulation Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Injectable Drug Delivery Formulation Market

Injectable Drug Delivery Formulation Market

The global market for Injectable Drug Delivery Formulation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Injectable Drug Delivery Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Drug Delivery Formulation.
The Injectable Drug Delivery Formulation market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Drug Delivery Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Drug Delivery Formulation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Injectable Drug Delivery Formulation Market Report

Report Metric Details
Report Name Injectable Drug Delivery Formulation Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Becton, Dickinson and Company (US), Baxter International Inc. (US), Gerresheimer AG (Germany), Pfizer, Inc. (US), Schott AG (Germany), Sandoz (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (US)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Injectable Drug Delivery Formulation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Injectable Drug Delivery Formulation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Injectable Drug Delivery Formulation Market report?

Ans: The main players in the Injectable Drug Delivery Formulation Market are Becton, Dickinson and Company (US), Baxter International Inc. (US), Gerresheimer AG (Germany), Pfizer, Inc. (US), Schott AG (Germany), Sandoz (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (US)

What are the Application segmentation covered in the Injectable Drug Delivery Formulation Market report?

Ans: The Applications covered in the Injectable Drug Delivery Formulation Market report are Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Others

What are the Type segmentation covered in the Injectable Drug Delivery Formulation Market report?

Ans: The Types covered in the Injectable Drug Delivery Formulation Market report are Conventional Drug Delivery Formulations, Novel Drug Delivery Formulations, Long-acting Formulations

Recommended Reports

Drug Delivery Devices

Formulation & Excipients

Injection & Therapy Drugs

1 Injectable Drug Delivery Formulation Market Overview
1.1 Product Definition
1.2 Injectable Drug Delivery Formulation by Type
1.2.1 Global Injectable Drug Delivery Formulation Market Value Comparison by Type (2024 VS 2031)
1.2.2 Conventional Drug Delivery Formulations
1.2.3 Novel Drug Delivery Formulations
1.2.4 Long-acting Formulations
1.3 Injectable Drug Delivery Formulation by Application
1.3.1 Global Injectable Drug Delivery Formulation Market Value by Application (2024 VS 2031)
1.3.2 Autoimmune Diseases
1.3.3 Hormonal Disorders
1.3.4 Oncology
1.3.5 Orphan Diseases
1.3.6 Others
1.4 Global Injectable Drug Delivery Formulation Market Size Estimates and Forecasts
1.4.1 Global Injectable Drug Delivery Formulation Revenue 2020-2031
1.4.2 Global Injectable Drug Delivery Formulation Sales 2020-2031
1.4.3 Global Injectable Drug Delivery Formulation Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Injectable Drug Delivery Formulation Market Competition by Manufacturers
2.1 Global Injectable Drug Delivery Formulation Sales Market Share by Manufacturers (2020-2025)
2.2 Global Injectable Drug Delivery Formulation Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Injectable Drug Delivery Formulation Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Injectable Drug Delivery Formulation, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Drug Delivery Formulation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Drug Delivery Formulation, Product Type & Application
2.7 Global Key Manufacturers of Injectable Drug Delivery Formulation, Date of Enter into This Industry
2.8 Global Injectable Drug Delivery Formulation Market Competitive Situation and Trends
2.8.1 Global Injectable Drug Delivery Formulation Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Injectable Drug Delivery Formulation Players Market Share by Revenue
2.8.3 Global Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injectable Drug Delivery Formulation Market Scenario by Region
3.1 Global Injectable Drug Delivery Formulation Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Injectable Drug Delivery Formulation Sales by Region: 2020-2031
3.2.1 Global Injectable Drug Delivery Formulation Sales by Region: 2020-2025
3.2.2 Global Injectable Drug Delivery Formulation Sales by Region: 2026-2031
3.3 Global Injectable Drug Delivery Formulation Revenue by Region: 2020-2031
3.3.1 Global Injectable Drug Delivery Formulation Revenue by Region: 2020-2025
3.3.2 Global Injectable Drug Delivery Formulation Revenue by Region: 2026-2031
3.4 North America Injectable Drug Delivery Formulation Market Facts & Figures by Country
3.4.1 North America Injectable Drug Delivery Formulation Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Injectable Drug Delivery Formulation Sales by Country (2020-2031)
3.4.3 North America Injectable Drug Delivery Formulation Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injectable Drug Delivery Formulation Market Facts & Figures by Country
3.5.1 Europe Injectable Drug Delivery Formulation Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Injectable Drug Delivery Formulation Sales by Country (2020-2031)
3.5.3 Europe Injectable Drug Delivery Formulation Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Drug Delivery Formulation Market Facts & Figures by Region
3.6.1 Asia Pacific Injectable Drug Delivery Formulation Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Injectable Drug Delivery Formulation Sales by Region (2020-2031)
3.6.3 Asia Pacific Injectable Drug Delivery Formulation Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injectable Drug Delivery Formulation Market Facts & Figures by Country
3.7.1 Latin America Injectable Drug Delivery Formulation Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Injectable Drug Delivery Formulation Sales by Country (2020-2031)
3.7.3 Latin America Injectable Drug Delivery Formulation Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injectable Drug Delivery Formulation Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Drug Delivery Formulation Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2020-2031)
3.8.3 Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Drug Delivery Formulation Sales by Type (2020-2031)
4.1.1 Global Injectable Drug Delivery Formulation Sales by Type (2020-2025)
4.1.2 Global Injectable Drug Delivery Formulation Sales by Type (2026-2031)
4.1.3 Global Injectable Drug Delivery Formulation Sales Market Share by Type (2020-2031)
4.2 Global Injectable Drug Delivery Formulation Revenue by Type (2020-2031)
4.2.1 Global Injectable Drug Delivery Formulation Revenue by Type (2020-2025)
4.2.2 Global Injectable Drug Delivery Formulation Revenue by Type (2026-2031)
4.2.3 Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2020-2031)
4.3 Global Injectable Drug Delivery Formulation Price by Type (2020-2031)
5 Segment by Application
5.1 Global Injectable Drug Delivery Formulation Sales by Application (2020-2031)
5.1.1 Global Injectable Drug Delivery Formulation Sales by Application (2020-2025)
5.1.2 Global Injectable Drug Delivery Formulation Sales by Application (2026-2031)
5.1.3 Global Injectable Drug Delivery Formulation Sales Market Share by Application (2020-2031)
5.2 Global Injectable Drug Delivery Formulation Revenue by Application (2020-2031)
5.2.1 Global Injectable Drug Delivery Formulation Revenue by Application (2020-2025)
5.2.2 Global Injectable Drug Delivery Formulation Revenue by Application (2026-2031)
5.2.3 Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2020-2031)
5.3 Global Injectable Drug Delivery Formulation Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Becton, Dickinson and Company (US)
6.1.1 Becton, Dickinson and Company (US) Company Information
6.1.2 Becton, Dickinson and Company (US) Description and Business Overview
6.1.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Portfolio
6.1.5 Becton, Dickinson and Company (US) Recent Developments/Updates
6.2 Baxter International Inc. (US)
6.2.1 Baxter International Inc. (US) Company Information
6.2.2 Baxter International Inc. (US) Description and Business Overview
6.2.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Portfolio
6.2.5 Baxter International Inc. (US) Recent Developments/Updates
6.3 Gerresheimer AG (Germany)
6.3.1 Gerresheimer AG (Germany) Company Information
6.3.2 Gerresheimer AG (Germany) Description and Business Overview
6.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Portfolio
6.3.5 Gerresheimer AG (Germany) Recent Developments/Updates
6.4 Pfizer, Inc. (US)
6.4.1 Pfizer, Inc. (US) Company Information
6.4.2 Pfizer, Inc. (US) Description and Business Overview
6.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Portfolio
6.4.5 Pfizer, Inc. (US) Recent Developments/Updates
6.5 Schott AG (Germany)
6.5.1 Schott AG (Germany) Company Information
6.5.2 Schott AG (Germany) Description and Business Overview
6.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Schott AG (Germany) Injectable Drug Delivery Formulation Product Portfolio
6.5.5 Schott AG (Germany) Recent Developments/Updates
6.6 Sandoz (Germany)
6.6.1 Sandoz (Germany) Company Information
6.6.2 Sandoz (Germany) Description and Business Overview
6.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sandoz (Germany) Injectable Drug Delivery Formulation Product Portfolio
6.6.5 Sandoz (Germany) Recent Developments/Updates
6.7 Teva Pharmaceutical Industries Ltd. (Israel)
6.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Information
6.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Description and Business Overview
6.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Portfolio
6.7.5 Teva Pharmaceutical Industries Ltd. (Israel) Recent Developments/Updates
6.8 Eli Lilly and Company (US)
6.8.1 Eli Lilly and Company (US) Company Information
6.8.2 Eli Lilly and Company (US) Description and Business Overview
6.8.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Portfolio
6.8.5 Eli Lilly and Company (US) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Drug Delivery Formulation Industry Chain Analysis
7.2 Injectable Drug Delivery Formulation Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Drug Delivery Formulation Production Mode & Process Analysis
7.4 Injectable Drug Delivery Formulation Sales and Marketing
7.4.1 Injectable Drug Delivery Formulation Sales Channels
7.4.2 Injectable Drug Delivery Formulation Distributors
7.5 Injectable Drug Delivery Formulation Customer Analysis
8 Injectable Drug Delivery Formulation Market Dynamics
8.1 Injectable Drug Delivery Formulation Industry Trends
8.2 Injectable Drug Delivery Formulation Market Drivers
8.3 Injectable Drug Delivery Formulation Market Challenges
8.4 Injectable Drug Delivery Formulation Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Becton Dickinson and Company (US)
Baxter International, Inc. (US)
Gerresheimer AG (Germany)
Pfizer Inc. (US)
Schott AG (Germany)
Sandoz (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (US)
List of Tables
 Table 1. Global Injectable Drug Delivery Formulation Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Injectable Drug Delivery Formulation Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Injectable Drug Delivery Formulation Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Injectable Drug Delivery Formulation Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Injectable Drug Delivery Formulation Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Injectable Drug Delivery Formulation Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Injectable Drug Delivery Formulation Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Injectable Drug Delivery Formulation Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Injectable Drug Delivery Formulation, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Injectable Drug Delivery Formulation, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Injectable Drug Delivery Formulation, Product Type & Application
 Table 12. Global Key Manufacturers of Injectable Drug Delivery Formulation, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Injectable Drug Delivery Formulation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Drug Delivery Formulation as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Injectable Drug Delivery Formulation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Injectable Drug Delivery Formulation Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2020-2025)
 Table 19. Global Injectable Drug Delivery Formulation Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2026-2031)
 Table 21. Global Injectable Drug Delivery Formulation Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2020-2025)
 Table 23. Global Injectable Drug Delivery Formulation Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2026-2031)
 Table 25. North America Injectable Drug Delivery Formulation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Injectable Drug Delivery Formulation Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Injectable Drug Delivery Formulation Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Injectable Drug Delivery Formulation Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Injectable Drug Delivery Formulation Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Injectable Drug Delivery Formulation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Injectable Drug Delivery Formulation Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Injectable Drug Delivery Formulation Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Injectable Drug Delivery Formulation Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Injectable Drug Delivery Formulation Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Injectable Drug Delivery Formulation Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Injectable Drug Delivery Formulation Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Injectable Drug Delivery Formulation Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Injectable Drug Delivery Formulation Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Injectable Drug Delivery Formulation Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Injectable Drug Delivery Formulation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Injectable Drug Delivery Formulation Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Injectable Drug Delivery Formulation Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Injectable Drug Delivery Formulation Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Injectable Drug Delivery Formulation Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Injectable Drug Delivery Formulation Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Injectable Drug Delivery Formulation Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2020-2025)
 Table 53. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2026-2031)
 Table 54. Global Injectable Drug Delivery Formulation Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Injectable Drug Delivery Formulation Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2020-2025)
 Table 57. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2026-2031)
 Table 58. Global Injectable Drug Delivery Formulation Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Injectable Drug Delivery Formulation Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Injectable Drug Delivery Formulation Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Injectable Drug Delivery Formulation Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2020-2025)
 Table 63. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2026-2031)
 Table 64. Global Injectable Drug Delivery Formulation Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Injectable Drug Delivery Formulation Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2020-2025)
 Table 67. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2026-2031)
 Table 68. Global Injectable Drug Delivery Formulation Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Injectable Drug Delivery Formulation Price (USD/Pcs) by Application (2026-2031)
 Table 70. Becton, Dickinson and Company (US) Company Information
 Table 71. Becton, Dickinson and Company (US) Description and Business Overview
 Table 72. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product
 Table 74. Becton, Dickinson and Company (US) Recent Developments/Updates
 Table 75. Baxter International Inc. (US) Company Information
 Table 76. Baxter International Inc. (US) Description and Business Overview
 Table 77. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product
 Table 79. Baxter International Inc. (US) Recent Developments/Updates
 Table 80. Gerresheimer AG (Germany) Company Information
 Table 81. Gerresheimer AG (Germany) Description and Business Overview
 Table 82. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product
 Table 84. Gerresheimer AG (Germany) Recent Developments/Updates
 Table 85. Pfizer, Inc. (US) Company Information
 Table 86. Pfizer, Inc. (US) Description and Business Overview
 Table 87. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product
 Table 89. Pfizer, Inc. (US) Recent Developments/Updates
 Table 90. Schott AG (Germany) Company Information
 Table 91. Schott AG (Germany) Description and Business Overview
 Table 92. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Schott AG (Germany) Injectable Drug Delivery Formulation Product
 Table 94. Schott AG (Germany) Recent Developments/Updates
 Table 95. Sandoz (Germany) Company Information
 Table 96. Sandoz (Germany) Description and Business Overview
 Table 97. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Sandoz (Germany) Injectable Drug Delivery Formulation Product
 Table 99. Sandoz (Germany) Recent Developments/Updates
 Table 100. Teva Pharmaceutical Industries Ltd. (Israel) Company Information
 Table 101. Teva Pharmaceutical Industries Ltd. (Israel) Description and Business Overview
 Table 102. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product
 Table 104. Teva Pharmaceutical Industries Ltd. (Israel) Recent Developments/Updates
 Table 105. Eli Lilly and Company (US) Company Information
 Table 106. Eli Lilly and Company (US) Description and Business Overview
 Table 107. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product
 Table 109. Eli Lilly and Company (US) Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Injectable Drug Delivery Formulation Distributors List
 Table 113. Injectable Drug Delivery Formulation Customers List
 Table 114. Injectable Drug Delivery Formulation Market Trends
 Table 115. Injectable Drug Delivery Formulation Market Drivers
 Table 116. Injectable Drug Delivery Formulation Market Challenges
 Table 117. Injectable Drug Delivery Formulation Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Injectable Drug Delivery Formulation
 Figure 2. Global Injectable Drug Delivery Formulation Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Injectable Drug Delivery Formulation Market Share by Type: 2024 & 2031
 Figure 4. Conventional Drug Delivery Formulations Product Picture
 Figure 5. Novel Drug Delivery Formulations Product Picture
 Figure 6. Long-acting Formulations Product Picture
 Figure 7. Global Injectable Drug Delivery Formulation Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Injectable Drug Delivery Formulation Market Share by Application: 2024 & 2031
 Figure 9. Autoimmune Diseases
 Figure 10. Hormonal Disorders
 Figure 11. Oncology
 Figure 12. Orphan Diseases
 Figure 13. Others
 Figure 14. Global Injectable Drug Delivery Formulation Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Injectable Drug Delivery Formulation Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Injectable Drug Delivery Formulation Sales (2020-2031) & (K Pcs)
 Figure 17. Global Injectable Drug Delivery Formulation Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Injectable Drug Delivery Formulation Report Years Considered
 Figure 19. Injectable Drug Delivery Formulation Sales Share by Manufacturers in 2024
 Figure 20. Global Injectable Drug Delivery Formulation Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Injectable Drug Delivery Formulation Players: Market Share by Revenue in Injectable Drug Delivery Formulation in 2024
 Figure 22. Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Injectable Drug Delivery Formulation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Injectable Drug Delivery Formulation Sales Market Share by Country (2020-2031)
 Figure 25. North America Injectable Drug Delivery Formulation Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Injectable Drug Delivery Formulation Sales Market Share by Country (2020-2031)
 Figure 29. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Injectable Drug Delivery Formulation Revenue Market Share by Region (2020-2031)
 Figure 37. China Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Injectable Drug Delivery Formulation Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Injectable Drug Delivery Formulation Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Injectable Drug Delivery Formulation Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Injectable Drug Delivery Formulation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Injectable Drug Delivery Formulation by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Injectable Drug Delivery Formulation by Type (2020-2031)
 Figure 59. Global Injectable Drug Delivery Formulation Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Injectable Drug Delivery Formulation by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Injectable Drug Delivery Formulation by Application (2020-2031)
 Figure 62. Global Injectable Drug Delivery Formulation Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Injectable Drug Delivery Formulation Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Injectable Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Sterile Injectables Market Research Report 2024
Injectable Drug Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Injectable Nanomedicines Market Insights Forecast to 2030
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Advanced Targeted Drug Delivery Market Research Report 2025
Polymers Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemical Dosing Units Market Research Report 2025
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Infusion Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Treatment Planning Software Market Research Report 2025
Global Diagnostic Guidewire Market Research Report 2024
Nanotechnology Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alternative Drug Delivery Systems Market Research Report 2024
Global Drug Excipients Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions